1.Gliosarcoma: a case with unusual epithelial feature.
Dong Sug KIM ; Shin Kwang KANG ; Je Geun CHI
Journal of Korean Medical Science 1999;14(3):345-350
Astrocytic tumors, particularly gliosarcoma, may contain epithelial features in the form of trabecular, adenoid, papillary arrangement, and squamous metaplasia. A case of gliosarcoma with unusual epithelial feature is described. The patient was a 60-year-old male with frequent seizures. The mass was 4 cm and in the left frontal lobe. Trabecular or rarely adenoid arrangement of neoplastic astrocytes was present in the mucinous stroma, and there was a distinctive transition between the trabecular area and typical anaplastic astrocytoma. The tumor cells in the trabecular area showed positive immunostain for glial fibrillary acidic protein, but did not react with various kinds of cytokeratin. The sarcomatous area was undifferentiated and was not labeled by factor-VIII, desmin, and anti-smooth muscle actin. Occurrence and histogenesis of epithelial features in gliosarcoma are reviewed. The importance to recognize the existence of epithelial feature in malignant astrocytic tumor is emphasized.
Brain Neoplasms/surgery
;
Brain Neoplasms/pathology*
;
Case Report
;
Epithelium/pathology
;
Gliosarcoma/surgery
;
Gliosarcoma/pathology*
;
Human
;
Magnetic Resonance Imaging
;
Male
;
Middle Age
2.Gliosarcoma of cerebral hemispheres: a clinicopathologic study of 10 cases.
Zhen HUO ; Zhiyong LIANG ; Yuan LI ; Jie SHEN ; Yalan BI ; Yunxiao MENG ; Shuying ZHANG ; Yufeng LUO ; Jinling CAO ; Di YANG
Chinese Journal of Pathology 2014;43(10):657-662
OBJECTIVETo study the clinical and pathologic features of gliosarcoma of cerebral hemispheres.
METHODSThe clinicopathologic features of 10 cases of gliosarcoma involving cerebral hemispheres were reviewed. Immunohistochemical study was carried out using EnVision method.
RESULTSThe mean age of the patients was 54 years and the male-to-female ratio was 6 to 4. Clinical symptoms included headache (6/10), nausea/vomiting (5/10), and sensory or motor impairment (4/10). Nine of the cases were primary gliosarcoma, with maximum diameter ranging from 2.4 to 5.5 cm (mean = 4.2 cm). The remaining case represented secondary gliosarcoma involving skull base and extracranial tissues. Histologic examination showed a biphasic pattern in all cases. Regarding the glial component, there were 9 cases of pleomorphic glioblastoma and 1 case of giant cell glioblastoma. Reticulin stain was positive in all cases. Immunohistochemical study showed that the tumor cells variably expressed GFAP (10/10), p16 (4/10), EGFR (1/10), CD68 (1/10) and p53 (6/10). The Ki-67 index ranged from 15% to 70% (mean = 34%). Six patients had follow-up data available. One patient was disease-free for 45 months and 5 patients died of the disease at 3 to 17 months after the operation (mean duration of survival = 9 months).
CONCLUSIONSGliosarcoma is a highly aggressive tumor, often locates in the deeper part cerebral hemispheres and has a relatively short duration of symptoms. It carries a poor prognosis. GFAP immunostain and reticulin stain are helpful in confirming the diagnosis. p53 and p16 are also expressed in some cases.
Adult ; Brain Neoplasms ; metabolism ; pathology ; Cerebrum ; pathology ; Female ; Glioblastoma ; metabolism ; pathology ; Gliosarcoma ; metabolism ; pathology ; Humans ; Male ; Middle Aged ; Neuroglia ; pathology
3.Gliosarcoma of the Cerebellar Hemisphere: a Case Report and Review of the Literature.
Sung Kyoung MOON ; Eui Jong KIM ; Woo Suk CHOI ; Chang Woo RYU ; Bong Jin PARK ; Juhie LEE
Korean Journal of Radiology 2010;11(5):566-570
Gliosarcoma is a rare central nervous system tumor usually located in the supratentorial area. Here we report a rare case of a gliosarcoma that developed in the cerebellar hemisphere in a 70-year-old woman. Computed tomography (CT) and magnetic resonance imaging (MRI) of the brain revealed an infratentorial mass of which radiological features were similar to those of glioblastoma. The tumor was diagnosed by pathology as a gliosarcoma. Though rare, gliosarcoma should be considered in the differential diagnosis of infratentorial tumors with radiological features of glioblastoma or metastasis in elderly patients.
Aged
;
Cerebellar Neoplasms/*diagnosis/pathology/surgery
;
Contrast Media/diagnostic use
;
Female
;
Gliosarcoma/*diagnosis/pathology/surgery
;
Humans
;
Magnetic Resonance Imaging
;
Tomography, X-Ray Computed
4.Spindle cell tumors of central nervous system.
Chinese Journal of Pathology 2010;39(3):202-204
Antigens, CD34
;
metabolism
;
Astrocytoma
;
metabolism
;
pathology
;
Carcinoma
;
metabolism
;
pathology
;
Central Nervous System Neoplasms
;
metabolism
;
pathology
;
Ependymoma
;
metabolism
;
pathology
;
Fibroma
;
metabolism
;
pathology
;
Ganglioglioma
;
metabolism
;
pathology
;
Glial Fibrillary Acidic Protein
;
metabolism
;
Glioma
;
metabolism
;
pathology
;
Gliosarcoma
;
metabolism
;
pathology
;
Humans
;
Immunohistochemistry
;
Neoplasms, Neuroepithelial
;
metabolism
;
pathology
;
Solitary Fibrous Tumors
;
metabolism
;
pathology
5.Preliminary experiences with intraoperative radiation therapy (IORT) for the treatment of brain tumors.
Yong Gu CHUNG ; Chul Yong KIM ; Hoon Kap LEE ; Ki Chan LEE ; Jeong Wha CHU ; Myung Sun CHOI
Journal of Korean Medical Science 1995;10(6):449-452
Ten brain tumor patients underwent wide resection of the tumor followed by Intraoperative Radiation Therapy (IORT) at the first surgery or at the second salvage surgery after failure of conventional external beam irradiation. Two patients(1 meningioma, 1 glioblastoma multiforme) were treated at the first surgery and 8 patients(3 anaplastic astrocytoma, 3 glioblastoma multiforme, 1 meningioma, 1 gliosarcoma) were treated after salvage surgery. The IORT doses were ranged from 15-25 Gy depending on the tumor volume and previous radiation therapy. The neurological status(Karnofsky performance status) was improved in 4 cases, not changed in 6 cases after IORT. There were several complications after IORT; radiation necrosis, communicating hydrocephalus, wound infection, and abnormal CT findings such as diffuse low density area in an around operation site. The radiation necrosis was confirmed by operation in a recurrent meningioma patient 12 months after IORT. At follow-up, ranging from 1 to 16 months, there was no deaths. Based on our limited experiences, the IORT might be one of the adjuvant therapeutic modalities especially for the malignant brain tumors and unresectable huge meningioma.
Adult
;
Astrocytoma/radiotherapy/surgery
;
Brain Neoplasms/pathology/*radiotherapy/*surgery
;
Combined Modality Therapy
;
Female
;
Glioblastoma/radiotherapy/surgery
;
Gliosarcoma/radiotherapy/surgery
;
Human
;
Intraoperative Care
;
Male
;
Meningioma/radiotherapy/surgery
;
Middle Age
;
Salvage Therapy